Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995
- 19 December 1985
- journal article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 313 (25), 1576-1580
- https://doi.org/10.1056/nejm198512193132504
Abstract
We treated four patients with acromegaly for 8 to 24 weeks with SMS 201–995, the long-acting somatostatin analogue, in dosages of 100 to 300 μg a day given subcutaneously. A rapid amelioration of the clinical signs and symptoms and near normalization of laboratory test results occurred in all patients. Mean plasma growth hormone concentrations (±S.E.M.), as measured over 24 hours, fell from an initial value of 57±18 μg per liter to 7.5±2 μg per liter at the end of the investigational period. Likewise, levels of plasma somatomedin-C, which were originally elevated in all patients, dropped to the normal or nearly normal range. The suppression of insulin secretion and the resulting hyperglycemia that were observed at the beginning of treatment became less marked as therapy progressed. There was evidence of slight tumor shrinkage in three of the subjects. No side effects were recorded throughout the treatment period. These preliminary results suggest that SMS 201–995 represents an additional option for the management of acromegaly, especially in patients who do not benefit sufficiently from surgery or radiotherapy and do not respond well to treatment with dopaminergic drugs. (N Engl J Med 1985; 313:1576–80.)Keywords
This publication has 15 references indexed in Scilit:
- Long term treatment of acromegaly with a long acting analogue of somatostatin.BMJ, 1985
- LONG-ACTING AND SELECTIVE SUPPRESSION OF GROWTH HORMONE SECRETION BY SOMATOSTATIN ANALOGUE SMS 201-995 IN ACROMEGALYThe Lancet, 1984
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- New Criteria for Evaluation of AcromegalyThe New England Journal of Medicine, 1979
- Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-CThe New England Journal of Medicine, 1979
- REDUCTION OF PITUITARY-TUMOUR SIZE IN PATIENTS WITH PROLACTINOMAS AND ACROMEGALY TREATED WITH BROMOCRIPTINE WITH OR WITHOUT RADIOTHERAPYThe Lancet, 1979
- Long-term treatment of acromegaly with bromocriptine.BMJ, 1977
- A COMPARISON OF THE EFFECT OF LEVODOPA AND SOMATOSTATIN ON THE PLASMA LEVELS OF GROWTH HORMONE, INSULIN, GLUCAGON AND PROLACTIN IN ACROMEGALYClinical Endocrinology, 1976
- Effect of Somatostatin in Patients with AcromegalyThe New England Journal of Medicine, 1974
- Growth Hormone Release Inhibiting Hormone in AcromegalyBMJ, 1974